Status:
COMPLETED
Study of the Effect of the Drug Gabapentin on Postoperative Pain and Incidence of Postoperative Nausea and Vomiting
Lead Sponsor:
Medical University of South Carolina
Conditions:
Obesity, Morbid
Postoperative Pain
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this research study is to evaluate the drug gabapentin (Neurontin®) for its ability to reduce postoperative pain, the need for morphine-like pain medication, and the severity and freque...
Detailed Description
The occurrence of morbid obesity is at epidemic proportions in the United States. Laparoscopic gastric bypass is an effective means of safely facilitating patient weight loss and thereby drastically r...
Eligibility Criteria
Inclusion
- Patients undergoing laparoscopic gastric bypass surgery
- Age \> 18 years
Exclusion
- Patients under the age of 18 years
- Patients who undergo open gastric bypass
- Patients with a history of chronic pain treated with pregabalin, gabapentin or opioids
- Patients with a history of chronic renal disease (creatinine \> 1.3)
- Patients with a history of bleeding gastric ulcer
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT00886236
Start Date
February 1 2008
End Date
January 1 2011
Last Update
September 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425